|
NUVL | Nuvalent, Inc. |
|
|
NUVL | Nuvalent, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.12 |
| Leverage | 13.73% |
| Market Cap | $ 6.8B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -380.2m |
| Margin | -2179.98% |
None